COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

12/04/2018 - 07:06

REGULATED INFORMATION GHENT, Belgium, 12 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

TiGenix reports 2017 full year results

12/04/2018 - 07:01

PRESS RELEASE Regulated information inside information TiGenix reports 2017 full year results Leuven (BELGIUM) - April 12, 2018, 7:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical [...]

TiGenix présente ses résultats de l'an 2017

12/04/2018 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES TiGenix présente ses résultats de l'an 2017 Louvain (BELGIQUE) - 12 avril 2018, 07h00 CEST - TiGenix NV (Euronext Brussels et NASDAQ : TIG), [...]

Sanofi to invest €350 million in Canadian vaccine facility

12/04/2018 - 07:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi to invest €350 million in Canadian vaccine facility Expansion demonstrates company's commitment to innovation and leadership in global public health New [...]

Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada

12/04/2018 - 07:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi va investir 350 millions d'euros dans une unité de production de vaccins au Canada Un agrandissement qui illustre l'engagement de l'entreprise en [...]

Fagron realises organic turnover growth of 6.8%

12/04/2018 - 07:01

Regulated information Nazareth (Belgium) / Rotterdam (The Netherlands), 12 April 2018 Fagron realises organic turnover growth of 6.8% Key points Organic turnover growth in Europe, South America and North America. Europe [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

12/04/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 12 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

argenx to receive third preclinical milestone payment from collaboration with LEO Pharma - Milestone associated with CTA approval for ARGX-112

12/04/2018 - 07:01

Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]

Atea Pharmaceuticals Reports Positive Proof of Concept Clinical Data With AT-527 for the Treatment of Chronic Hepatitis C

12/04/2018 - 07:00

AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor which has been safe and well tolerated in this ongoing multiple part trial AT-527 exhibits potent antiviral activity in genotype (GT)- [...]

Novavax Prices Public Offering of Common Stock

12/04/2018 - 02:50

GAITHERSBURG, Md., April 11, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX ), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced that it [...]

Genesis HealthCare Announces Planned Divestiture of Facilities in Texas

12/04/2018 - 02:28

KENNETT SQUARE, Penn., April 11, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN ), one of the largest post-acute care providers in the United States, today announced it has signed a [...]

VANC Announces Agreement for Acquisition of Corozon Platform

12/04/2018 - 00:24

VANCOUVER, British Columbia, April 11, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ”) (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce it has entered into a defintive agreement with Corozon Consulting [...]

Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases

11/04/2018 - 23:24

Genevant aims to advance 5-10 product candidates into the clinic by 2020 across RNAi, mRNA, and gene editing modalities using Arbutus’ LNP and ligand conjugate platforms Genevant will be led by Executive Chairman Paris [...]

Extendicare Completes Acquisition of Lynde Creek Retirement Community

11/04/2018 - 22:56

MARKHAM, Ontario and ETOBICOKE, Ontario , April 11, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced that it has completed the previously disclosed acquisition from [...]

Bellicum Announces Clinical Hold Lifted on U.S. Studies of BPX-501

11/04/2018 - 22:17

HOUSTON, April 11, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Reata Provides Update on the Phase 2 Portion of the CARDINAL Study of Bardoxolone Methyl in Patients With Alport Syndrome

11/04/2018 - 22:15

Bardoxolone Treatment Produced Significant Increase in Kidney Function Maintained Through Week 36 Conference Call With Management Scheduled Thursday, April 12 th at 8:30am ET IRVING, Texas, April 11, 2018 (GLOBE [...]

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11/04/2018 - 22:05

MENLO PARK, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]

Aileron Therapeutics Announces Publication by Researchers at Albert Einstein College of Medicine of ALRN-6924 Nonclinical Data in Acute Myeloid Leukemia

11/04/2018 - 22:05

Nonclinical data featured in Science Translational Medicine show dual inhibition of MDM2 and MDMX restored p53 function and demonstrated strong response rates in AML model CAMBRIDGE, Mass., April 11, 2018 (GLOBE [...]

ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting

11/04/2018 - 22:05

MOUNTAIN VIEW, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced the presentation of positive safety, efficacy and quality of life results from the Company’s successfully [...]